Navidoxine 25/50mg Tablets
₨275.00
Pack Size: 10’s
Composition: Meclozine (25mg), Pyridoxine (50mg)
Pharmaceutical form: Tablets
Brand Name: AGP
Availability: In stock
- Description
- PRECAUTIONS
- Additional Information
- Reviews (0)
Description
Navidoxine 25/50mg Tablets
Navidoxine 25/50mg Tablets belongs to a class of medicines known as antihistamines. It is a prescription medicine used to treat motion sickness (nausea due to motion, especially while traveling in a moving vehicle), vertigo (spinning sensation or dizziness), or Meniere’s disease (problems with balance).
Dosage and administration: This product should be used in pregnant women only if absolutely necessary, and duration should be as short as possible and dosage should not exceed 50mg of meclozine per day.
Adults and adolescents aged over 12 years should take two tablets two hours before travel. You can then take one tablet every eight hours during the journey if needed. Children aged 5 to 12 years should take one tablet two hours before travel.
Adults, elderly and children over 12 years: 2 tablets three times a day. Children 5 to 12 years: One half the adult dose. These doses should not be exceeded. Adults, elderly and children over 12 years: 2 tablets 2 hours before you travel and 1 tablet every 8 hours during your journey.
Uses Of Navidoxine 25/50mg Tablets
- Motion Sickness
- Vertigo
Side Effects Of Navidoxine 25/50mg Tablets
- Blurred vision
- Drymouth
- Drowsiness
- Fatigue
- Headache
- Palpitation
When Not To Use
- This medication is contraindicated in patients with kidney impairment, closed angle glaucome (pressure in the eye).
- Consult your doctor before using this medication.
Inform your doctor if you have any history of breathing issues like asthma or the condition known as glaucoma (high blood pressure within the eyes) and heart problems and seizures, stomach disorders, or stomach pains This medication may cause sleepiness.
Be the first to review “Navidoxine 25/50mg Tablets”
You must be logged in to post a review.
Reviews
There are no reviews yet.